StreetInsider.com Notable Analyst Rating Changes 09/28
More News related to BMRN
- BioMarin to Present at the NASDAQ OMX 23rd Investor Program
- BioMarin (BMRN) Responds to News of Contamination at Genzyme (GENZ) Plant; Says Aldurazyme, Naglazyme Won't Be Impacted
- Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme
- United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
- BioMarin to Present at the Credit Suisse Healthcare Conference
More News related to CMG
- Chipotle Finalizes London Location
- Computer Modelling Group Announces Second Quarter Results
- Chipotle Mexican Grill, Inc. Announces Share Repurchase Agreement
- Computer Modelling Group Declares Quarterly Dividend
- After-Hours Movers 10/22: AMZN, SYNA, ALGN, RNOW, COF, PWER Higher; HOKU, SPWRA, BRCM, BJRI, SNV, IBKR Lower
More News related to LUM
- Luminent Mortgage (LUM) Says Repo Lender Alleges A Default May Exist
- StreetInsider.com Unusual 11 Mid-Day Movers 10/02
- StreetInsider.com Pre-Open Movers 10/02
- Luminent Mortgage (LUM) Raises Money and Repays Debts
- StreetInsider.com Notable Analyst Rating Changes 09/28
Notable Analyst Rating Changes:
UPGRADES:
Merrill Lynch upgrades Target (NYSE: TGT) from Neutral to Buy with a $77 price target, citing likelihood the company will sell its credit-card portfolio.
Goldman Sachs upgrades Packaging Corp. of America (NYSE: PKG) from Neutral to Buy and adds the stock to their Conviction Buy list.
Deutsche Bank upgrades Luminent Mortgage (NYSE: LUM) from Sell to Hold, but reduces their price target from $3 to $1.50. The firm said, "we believe the portfolio is stabilizing and shares are appropriately valued given the current environment."
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES:
Citigroup downgrades Chipotle Mexican Grill Inc (NYSE: CMG) from Buy to Hold with a $120 price target. The firm cited, "recent strong performance and given valuation that appears full, in our view. We continue to believe underlying fundamentals remain strong, however."
Merrill Lynch downgrades Vertex Pharmaceuticals (Nasdaq: VRTX) from Buy to Neutral
Goldman Sachs downgrades MeadWestvaco (NYSE: MWV) from Buy to Neutral
For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades
NEW COVERAGE:
Citigroup initiates coverage on BioMarin Pharmaceutical Inc (Nasdaq: BMRN) with a Buy rating and $30 price target. The firm said, "Besides strong growth from both Aldurazyme and Naglazyme, we believe Kuvan will demonstrate a robust market launch."
JP Morgan initiates coverage on Carrols Restaurant (Nasdaq: TAST) with an Overweight rating.
Goldman Sachs downgrades MeadWestvaco (NYSE: MWV) from Buy to Neutral
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
For more StreetInsider.com \'Special Reports\' Go Here: http://www.streetinsider.com/Special+Reports
Related Categories
General NewsSpecial Reports
Stocks Mentioned
-0.38
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
